Position in LLY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,495,228,697
-$105,999,513 QoQ
Shares Held
1,625,655
+9.1% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2026CallValue
$919,770
CallShares
1,000
PutValue
$1,563,609
PutShares
1,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026RAYMOND JAMES FINANCIAL INC holds $9,418,688,045 across 17 Drug Manufacturers - General names. LLY ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,238,839 | $2,502,781,802 | |
| 2 | ABBV |
AbbVie Inc.
|
9,604,349 | $2,088,849,862 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,625,655 | $1,495,228,697 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,585,514 | $792,171,477 | |
| 5 | AMGN |
Amgen Inc
|
1,620,353 | $570,121,202 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,561,652 | $357,017,436 | |
| 7 | AZN |
Astrazeneca PLC
|
1,736,955 | $342,562,263 | |
| 8 | PFE |
Pfizer Inc
|
11,674,216 | $327,811,983 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $919,770 | 1,000 | Call | Defined | 2026-05-14 | |
| 2026-03-31 | $1,563,609 | 1,700 | Put | Defined | 2026-05-14 | |
| 2026-03-31 | $1,495,228,697 | 1,625,655 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,601,228,210 | 1,489,958 | Shares | Defined | 2026-02-18 | |
| 2025-12-31 | $322,404 | 300 | Put | Defined | 2026-02-18 | |
| 2025-09-30 | $1,053,488,597 | 1,380,719 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,162,962,874 | 1,491,877 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,215,092,004 | 1,471,216 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,240,651,864 | 1,607,062 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||